A citation-based method for searching scientific literature

Sabine Pinter, Franziska Knodel, Michel Choudalakis, Philipp Schnee, Carolin Kroll, Marina Fuchs, Alexander Broehm, Sara Weirich, Mareike Roth, Stephan A Eisler, Johannes Zuber, Albert Jeltsch, Philipp Rathert. Nucleic Acids Res 2021
Times Cited: 3







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


R-loop stabilization represses antisense transcription at the Arabidopsis FLC locus.
Qianwen Sun, Tibor Csorba, Konstantina Skourti-Stathaki, Nicholas J Proudfoot, Caroline Dean. Science 2013
224
66

Fast gapped-read alignment with Bowtie 2.
Ben Langmead, Steven L Salzberg. Nat Methods 2012
66

The 3' processing of antisense RNAs physically links to chromatin-based transcriptional control.
Xiaofeng Fang, Zhe Wu, Oleg Raitskin, Kimberly Webb, Philipp Voigt, Tiancong Lu, Martin Howard, Caroline Dean. Proc Natl Acad Sci U S A 2020
17
33

R-loop resolution promotes co-transcriptional chromatin silencing.
Congyao Xu, Zhe Wu, Hong-Chao Duan, Xiaofeng Fang, Guifang Jia, Caroline Dean. Nat Commun 2021
16
33


Lsd1 and lsd2 control programmed replication fork pauses and imprinting in fission yeast.
Allyson Holmes, Laura Roseaulin, Catherine Schurra, Herve Waxin, Sarah Lambert, Mikel Zaratiegui, Robert A Martienssen, Benoit Arcangioli. Cell Rep 2012
22
33

Determinants of G quadruplex-induced epigenetic instability in REV1-deficient cells.
Davide Schiavone, Guillaume Guilbaud, Pierre Murat, Charikleia Papadopoulou, Peter Sarkies, Marie-Noëlle Prioleau, Shankar Balasubramanian, Julian E Sale. EMBO J 2014
84
33

Efficient Pre-mRNA Cleavage Prevents Replication-Stress-Associated Genome Instability.
Federico Teloni, Jone Michelena, Aleksandra Lezaja, Sinan Kilic, Christina Ambrosi, Shruti Menon, Jana Dobrovolna, Ralph Imhof, Pavel Janscak, Tuncay Baubec,[...]. Mol Cell 2019
32
33

FY is an RNA 3' end-processing factor that interacts with FCA to control the Arabidopsis floral transition.
Gordon G Simpson, Paul P Dijkwel, Victor Quesada, Ian Henderson, Caroline Dean. Cell 2003
272
33

PrimPol Is Required for Replicative Tolerance of G Quadruplexes in Vertebrate Cells.
Davide Schiavone, Stanislaw K Jozwiakowski, Marina Romanello, Guillaume Guilbaud, Thomas A Guilliam, Laura J Bailey, Julian E Sale, Aidan J Doherty. Mol Cell 2016
100
33

RNAi promotes heterochromatic silencing through replication-coupled release of RNA Pol II.
Mikel Zaratiegui, Stephane E Castel, Danielle V Irvine, Anna Kloc, Jie Ren, Fei Li, Elisa de Castro, Laura Marín, An-Yun Chang, Derek Goto,[...]. Nature 2011
118
33


Quantitative regulation of FLC via coordinated transcriptional initiation and elongation.
Zhe Wu, Robert Ietswaart, Fuquan Liu, Hongchun Yang, Martin Howard, Caroline Dean. Proc Natl Acad Sci U S A 2016
47
33

The Arabidopsis RNA-binding protein FCA requires a lysine-specific demethylase 1 homolog to downregulate FLC.
Fuquan Liu, Victor Quesada, Pedro Crevillén, Isabel Bäurle, Szymon Swiezewski, Caroline Dean. Mol Cell 2007
213
33

R-loop formation during S phase is restricted by PrimPol-mediated repriming.
Saša Šviković, Alastair Crisp, Sue Mei Tan-Wong, Thomas A Guilliam, Aidan J Doherty, Nicholas J Proudfoot, Guillaume Guilbaud, Julian E Sale. EMBO J 2019
53
33

Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives.
Alka Singh, Sameer Gupta, Manisha Sachan. Front Cell Dev Biol 2019
30
33

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Jordi Barretina, Giordano Caponigro, Nicolas Stransky, Kavitha Venkatesan, Adam A Margolin, Sungjoon Kim, Christopher J Wilson, Joseph Lehár, Gregory V Kryukov, Dmitriy Sonkin,[...]. Nature 2012
33

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
33

CHD4 regulates the DNA damage response and RAD51 expression in glioblastoma.
Lisa D McKenzie, John W LeClair, Kayla N Miller, Averey D Strong, Hilda L Chan, Edward L Oates, Keith L Ligon, Cameron W Brennan, Milan G Chheda. Sci Rep 2019
19
33

Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia.
Charles C Bell, Katie A Fennell, Yih-Chih Chan, Florian Rambow, Miriam M Yeung, Dane Vassiliadis, Luis Lara, Paul Yeh, Luciano G Martelotto, Aljosja Rogiers,[...]. Nat Commun 2019
74
33

ZMYND8 Co-localizes with NuRD on Target Genes and Regulates Poly(ADP-Ribose)-Dependent Recruitment of GATAD2A/NuRD to Sites of DNA Damage.
Cornelia G Spruijt, Martijn S Luijsterburg, Roberta Menafra, Rik G H Lindeboom, Pascal W T C Jansen, Raghu Ram Edupuganti, Marijke P Baltissen, Wouter W Wiegant, Moritz C Voelker-Albert, Filomena Matarese,[...]. Cell Rep 2016
66
33

Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance.
Brian B Liau, Cem Sievers, Laura K Donohue, Shawn M Gillespie, William A Flavahan, Tyler E Miller, Andrew S Venteicher, Christine H Hebert, Christopher D Carey, Scott J Rodig,[...]. Cell Stem Cell 2017
223
33

Targeting the JAK/STAT pathway in solid tumors.
Zoya Qureshy, Daniel E Johnson, Jennifer R Grandis. J Cancer Metastasis Treat 2020
27
33

Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines.
Jan J Bandolik, Alexandra Hamacher, Christian Schrenk, Robin Weishaupt, Matthias U Kassack. Int J Mol Sci 2019
17
33

JQ1 inhibits tumour growth in combination with cisplatin and suppresses JAK/STAT signalling pathway in ovarian cancer.
Tina Bagratuni, Nefeli Mavrianou, Nikolaos G Gavalas, Kimon Tzannis, Calliope Arapinis, Michael Liontos, Maria I Christodoulou, Nikolaos Thomakos, Dimitrios Haidopoulos, Alexandros Rodolakis,[...]. Eur J Cancer 2020
23
33

Long Neural Genes Harbor Recurrent DNA Break Clusters in Neural Stem/Progenitor Cells.
Pei-Chi Wei, Amelia N Chang, Jennifer Kao, Zhou Du, Robin M Meyers, Frederick W Alt, Bjoern Schwer. Cell 2016
159
33

S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013.
U Wagner, P Harter, F Hilpert, S Mahner, A Reuß, A du Bois, E Petru, W Meier, P Ortner, K König,[...]. Geburtshilfe Frauenheilkd 2013
29
33

Roles of the immune system in cancer: from tumor initiation to metastatic progression.
Hugo Gonzalez, Catharina Hagerling, Zena Werb. Genes Dev 2018
638
33

CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents.
Yoshiko Oyama, Shogo Shigeta, Hideki Tokunaga, Keita Tsuji, Masumi Ishibashi, Yusuke Shibuya, Muneaki Shimada, Jun Yasuda, Nobuo Yaegashi. PLoS One 2021
2
50

The NuRD component Mbd3 is required for pluripotency of embryonic stem cells.
Keisuke Kaji, Isabel Martín Caballero, Ruth MacLeod, Jennifer Nichols, Valerie A Wilson, Brian Hendrich. Nat Cell Biol 2006
277
33

Identifying ChIP-seq enrichment using MACS.
Jianxing Feng, Tao Liu, Bo Qin, Yong Zhang, Xiaole Shirley Liu. Nat Protoc 2012
774
33

Toll-like receptor expression in normal ovary and ovarian tumors.
Mingfu Zhou, Molly M McFarland-Mancini, Holly M Funk, Nader Husseinzadeh, Taofic Mounajjed, Angela F Drew. Cancer Immunol Immunother 2009
109
33

Enhancer variants: evaluating functions in common disease.
Olivia Corradin, Peter C Scacheri. Genome Med 2014
119
33


Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling.
Amanda Balboni Iniguez, Gabriela Alexe, Emily Jue Wang, Giovanni Roti, Sarvagna Patel, Liying Chen, Samuel Kitara, Amy Conway, Amanda L Robichaud, Björn Stolte,[...]. Cancer Cell 2018
32
33

The conjugated antimetabolite 5-FdU-ECyd and its cellular and molecular effects on platinum-sensitive vs. -resistant ovarian cancer cells in vitro.
Sarah Schott, Pauline Wimberger, Barbara Klink, Konrad Grützmann, Julian Puppe, Ulrike Sophie Wauer, Daniel Martin Klotz, Evelin Schröck, Jan Dominik Kuhlmann. Oncotarget 2017
4
33


Chromatin signatures of cancer.
Marc A Morgan, Ali Shilatifard. Genes Dev 2015
131
33

Janus Kinase 1 Plays a Critical Role in Mammary Cancer Progression.
Barbara L Wehde, Patrick D Rädler, Hridaya Shrestha, Stevi J Johnson, Aleata A Triplett, Kay-Uwe Wagner. Cell Rep 2018
22
33

BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer.
Yuhki Yokoyama, Hengrui Zhu, Jeong Heon Lee, Andrew V Kossenkov, Sherry Y Wu, Jayamanna M Wickramasinghe, Xiangfan Yin, Katherine C Palozola, Alessandro Gardini, Louise C Showe,[...]. Cancer Res 2016
82
33

BET inhibitor resistance emerges from leukaemia stem cells.
Chun Yew Fong, Omer Gilan, Enid Y N Lam, Alan F Rubin, Sarah Ftouni, Dean Tyler, Kym Stanley, Devbarna Sinha, Paul Yeh, Jessica Morison,[...]. Nature 2015
345
33

Regulation of DNA-damage responses and cell-cycle progression by the chromatin remodelling factor CHD4.
Sophie E Polo, Abderrahmane Kaidi, Linda Baskcomb, Yaron Galanty, Stephen P Jackson. EMBO J 2010
244
33


The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update.
Enis Afgan, Dannon Baker, Bérénice Batut, Marius van den Beek, Dave Bouvier, Martin Cech, John Chilton, Dave Clements, Nate Coraor, Björn A Grüning,[...]. Nucleic Acids Res 2018
33


Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex.
Jon S Zawistowski, Samantha M Bevill, Daniel R Goulet, Timothy J Stuhlmiller, Adriana S Beltran, Jose F Olivares-Quintero, Darshan Singh, Noah Sciaky, Joel S Parker, Naim U Rashid,[...]. Cancer Discov 2017
83
33

Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.
Yuan Cheng, Cai He, Manni Wang, Xuelei Ma, Fei Mo, Shengyong Yang, Junhong Han, Xiawei Wei. Signal Transduct Target Ther 2019
139
33

Update on first-line treatment of advanced ovarian carcinoma.
Z Kemp, Ja Ledermann. Int J Womens Health 2013
30
33

Activation of Oncogenic Super-Enhancers Is Coupled with DNA Repair by RAD51.
Idit Hazan, Jonathan Monin, Britta A M Bouwman, Nicola Crosetto, Rami I Aqeilan. Cell Rep 2019
16
33

Modification of enhancer chromatin: what, how, and why?
Eliezer Calo, Joanna Wysocka. Mol Cell 2013
799
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.